Laboratoire Avédis: what changed
Laboratoire Avédis
Largest movements
- Cash -€96,264
down €96,264 (-57.2%), from €168,350 to €72,085
mainly Accrued charges and deferred income (-€95,144) and Net result for the year (-€1,116)
- Accrued charges and deferred income -€95,144
no longer reported in 2025 (was €95,144)
- Gross operating margin +€5,958
up €5,958 (+91.1%), from -€6,540 to -€583
- Other operating charges -€821
down €821 (-62.7%), from €1,308 to €487
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €168,530 | €72,270 | -€96,260 | -57.1% |
| Fixed assets | 21/28 | €180 | €180 | = | 0.0% |
| Financial fixed assets | 28 | €180 | €180 | = | 0.0% |
| Current assets | 29/58 | €168,350 | €72,090 | -€96,260 | -57.2% |
| Amounts receivable within one year | 40/41 | - | €4 | +€4 | |
| Other amounts receivable | 41 | - | €4 | +€4 | |
| Cash at bank and in hand | 54/58 | €168,350 | €72,085 | -€96,264 | -57.2% |
| Total equity and liabilities | 10/49 | €168,530 | €72,270 | -€96,260 | -57.1% |
| Equity | 10/15 | €72,136 | €71,020 | -€1,116 | -1.5% |
| Contributions | 10/11 | €80,000 | €80,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€7,864 | -€8,980 | -€1,116 | -14.2% |
| Amounts payable | 17/49 | €96,394 | €1,250 | -€95,144 | -98.7% |
| Amounts payable within one year | 42/48 | €1,250 | €1,250 | = | 0.0% |
| Trade debts | 44 | €1,250 | €1,250 | = | 0.0% |
| Suppliers | 440/4 | €1,250 | €1,250 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €95,144 | - | -€95,144 | |
| Other operating charges | 640/8 | €1,308 | €487 | -€821 | -62.7% |
| Gross operating margin | 9900 | -€6,540 | -€583 | +€5,958 | +91.1% |
| Operating profit (loss) | 9901 | -€7,848 | -€1,070 | +€6,778 | +86.4% |
| Financial charges | 65/66B | €16 | €46 | +€30 | +189% |
| Recurring financial charges | 65 | €16 | €46 | +€30 | +189% |
| Profit (loss) for the period before taxes | 9903 | -€7,864 | -€1,116 | +€6,748 | +85.8% |
| Profit (loss) for the period | 9904 | -€7,864 | -€1,116 | +€6,748 | +85.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€7,864 | -€1,116 | +€6,748 | +85.8% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.